| 2014-10 | Oligopeptide complex for targeted non-viral gene delivery to adipocytes | 김용희 |
| 2013-02 | Protective effects of protein transduction domain-metallothionein fusion proteins against hypoxia- and oxidative stress-induced apoptosis in an ischemia/reperfusion rat model | 김용희 |
| 2021-04 | Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy | 김용희 |
| 2018-03 | Recent challenges and advances in genetically-engineered cell therapy | 김용희 |
| 2015-01 | Reducible Poly(Oligo-d-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model | 김용희 |
| 2018-08 | Regeneration of Anti-Hypoxic Myocardial Cells by Transduction of Mesenchymal Stem Cell-Derived Exosomes Containing Tat-Metallothionein Fusion Proteins | 김용희 |
| 2021-02 | RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis | 김용희 |
| 2016-10 | RNAi-mediated silencing of TNF-alpha converting enzyme to down-regulate soluble TNF-alpha production for treatment of acute and chronic colitis | 김용희 |
| 2012-03 | Self-Assembled Nanoparticles with Dual Effects of Passive Tumor Targeting and Cancer-Selective Anticancer Effects | 김용희 |
| 2013-02 | Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis | 김용희 |
| 2011-11 | Suicidal gene therapy against tumor using reducible poly (oligo-d-arginine) | 김용희 |
| 2011-12 | Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors | 김용희 |
| 2018-04 | Surfactant-free solubilization and systemic delivery of anti-cancer drug using low molecular weight methylcellulose | 김용희 |
| 2019-09 | Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance | 김용희 |
| 2014-09 | Thermo-reversible injectable gel based on enzymatically-chopped low molecular weight methylcellulose for exenatide and FGF 21 delivery to treat types 1 and 2 diabetes | 김용희 |
| 2017-09 | Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes | 김용희 |
| 2021-12 | White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes | 김용희 |
| 2011-08 | 다문화사회의 도래와 정책대응 | 김용희 |
| 2011-02 | 콘서트홀에서 음향설계를 위한 벽체 확산체의 평가 | 김용희 |
| 2021-09 | 키토산 기반 siRNA 나노전달체 제조 및 유전자 억제 효율 | 김용희 |
| 2012-02 | 建設産業의 프로젝트 파이낸싱 改善方案에 관한 硏究 | 김용희 |
